OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Response of gut microbiota in type 2 diabetes to hypoglycemic agents
Fanghua Zhang, Meng Wang, Junjie Yang, et al.
Endocrine (2019) Vol. 66, Iss. 3, pp. 485-493
Closed Access | Times Cited: 76
Fanghua Zhang, Meng Wang, Junjie Yang, et al.
Endocrine (2019) Vol. 66, Iss. 3, pp. 485-493
Closed Access | Times Cited: 76
Showing 26-50 of 76 citing articles:
Correlating the Gut Microbiome to Health and Disease
Tatiana M. Marques, John Peter Ganda-Mall, Richard A. Forsgård, et al.
Elsevier eBooks (2024), pp. 1-36
Closed Access | Times Cited: 5
Tatiana M. Marques, John Peter Ganda-Mall, Richard A. Forsgård, et al.
Elsevier eBooks (2024), pp. 1-36
Closed Access | Times Cited: 5
Current type 2 diabetes guidelines: Individualized treatment and how to make the most of metformin
Juliana C.N. Chan, Aimin Yang, Natural Chu, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. S3, pp. 55-74
Closed Access | Times Cited: 5
Juliana C.N. Chan, Aimin Yang, Natural Chu, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. S3, pp. 55-74
Closed Access | Times Cited: 5
Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents
Babiker Saad Almugadam, Yinhui Liu, Shen-min Chen, et al.
Journal of Diabetes Research (2020) Vol. 2020, pp. 1-14
Open Access | Times Cited: 39
Babiker Saad Almugadam, Yinhui Liu, Shen-min Chen, et al.
Journal of Diabetes Research (2020) Vol. 2020, pp. 1-14
Open Access | Times Cited: 39
The Effects of Metformin on the Gut Microbiota of Patients with Type 2 Diabetes: A Two-Center, Quasi-Experimental Study
Hanako Nakajima, Fumie Takewaki, Yoshitaka Hashimoto, et al.
Life (2020) Vol. 10, Iss. 9, pp. 195-195
Open Access | Times Cited: 35
Hanako Nakajima, Fumie Takewaki, Yoshitaka Hashimoto, et al.
Life (2020) Vol. 10, Iss. 9, pp. 195-195
Open Access | Times Cited: 35
Gut Microbiota in Bone Health and Diabetes
Julie Kristine Knudsen, Peter Derek Christian Leutscher, Suzette Sørensen
Current Osteoporosis Reports (2021) Vol. 19, Iss. 4, pp. 462-479
Closed Access | Times Cited: 32
Julie Kristine Knudsen, Peter Derek Christian Leutscher, Suzette Sørensen
Current Osteoporosis Reports (2021) Vol. 19, Iss. 4, pp. 462-479
Closed Access | Times Cited: 32
Habitual Dietary Intake Affects the Altered Pattern of Gut Microbiome by Acarbose in Patients with Type 2 Diabetes
Fumie Takewaki, Hanako Nakajima, Daiki Takewaki, et al.
Nutrients (2021) Vol. 13, Iss. 6, pp. 2107-2107
Open Access | Times Cited: 29
Fumie Takewaki, Hanako Nakajima, Daiki Takewaki, et al.
Nutrients (2021) Vol. 13, Iss. 6, pp. 2107-2107
Open Access | Times Cited: 29
Comparative Evaluation of the Effect of Metformin and Insulin on Gut Microbiota and Metabolome Profiles of Type 2 Diabetic Rats Induced by the Combination of Streptozotocin and High-Fat Diet
Nan Hu, Qi Zhang, Hui Wang, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 20
Nan Hu, Qi Zhang, Hui Wang, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 20
Genetic Loss of Sucrase-Isomaltase Function: Mechanisms, Implications, and Future Perspectives
Ninna Senftleber, Stina Ramne, Ida Moltke, et al.
The Application of Clinical Genetics (2023) Vol. Volume 16, pp. 31-39
Open Access | Times Cited: 11
Ninna Senftleber, Stina Ramne, Ida Moltke, et al.
The Application of Clinical Genetics (2023) Vol. Volume 16, pp. 31-39
Open Access | Times Cited: 11
A randomised double-blind placebo-controlled trial of a probiotic combination for manipulating the gut microbiota and managing metabolic syndrome
Rui Xiao, Ying Chen, Xiao Feng Zhu, et al.
Food Bioscience (2024) Vol. 59, pp. 104076-104076
Closed Access | Times Cited: 4
Rui Xiao, Ying Chen, Xiao Feng Zhu, et al.
Food Bioscience (2024) Vol. 59, pp. 104076-104076
Closed Access | Times Cited: 4
QiDiTangShen granules modulated the gut microbiome composition and improved bile acid profiles in a mouse model of diabetic nephropathy
Huili Wei, Lin Wang, Zhichao An, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 111061-111061
Open Access | Times Cited: 32
Huili Wei, Lin Wang, Zhichao An, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 111061-111061
Open Access | Times Cited: 32
Exploring the impact of type 2 diabetes and glucose-lowering drugs on gut microbiome dynamics
Hina Tariq, Niaz Muhammad Khan, Haseeb Manzoor, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access
Hina Tariq, Niaz Muhammad Khan, Haseeb Manzoor, et al.
Deleted Journal (2025) Vol. 2, Iss. 1
Open Access
The therapeutic success of approaches to the gastrointestinal microbiome modulation in the treatment of obesity, metabolic syndrome and type 2 diabetes mellitus
Anastasia A. Zabolotneva, О. П. Шатова, J. A. Agapova, et al.
Diabetes Mellitus (2025) Vol. 27, Iss. 6, pp. 598-610
Open Access
Anastasia A. Zabolotneva, О. П. Шатова, J. A. Agapova, et al.
Diabetes Mellitus (2025) Vol. 27, Iss. 6, pp. 598-610
Open Access
Implication of taxonomic abundance of gut microbiota in prediabetes: a systematic review
Iche Andriyani Liberty, Laily Hanifah, Hanna Farida Rachmat, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
Iche Andriyani Liberty, Laily Hanifah, Hanna Farida Rachmat, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
The use of exogenous feed enzymes in the nutrition of ruminants
Victoria V Grechkina, Е. В. Шейда, Olga Kvan, et al.
Agrarian science (2025) Vol. 1, Iss. 4, pp. 69-74
Open Access
Victoria V Grechkina, Е. В. Шейда, Olga Kvan, et al.
Agrarian science (2025) Vol. 1, Iss. 4, pp. 69-74
Open Access
Sargassum fusiformepolysaccharide is a potential auxiliary substance for metformin in the management of diabetes
Juan Wu, Rui‐Bo Jia, Donghui Luo, et al.
Food & Function (2022) Vol. 13, Iss. 5, pp. 3023-3035
Closed Access | Times Cited: 15
Juan Wu, Rui‐Bo Jia, Donghui Luo, et al.
Food & Function (2022) Vol. 13, Iss. 5, pp. 3023-3035
Closed Access | Times Cited: 15
Benefits of Huang Lian mediated by gut microbiota on HFD/STZ-induced type 2 diabetes mellitus in mice
Dan Li, Guangli Feng, Yue Li, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 8
Dan Li, Guangli Feng, Yue Li, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 8
Metformin-induced changes of the gut microbiota in patients with type 2 diabetes mellitus: results from a prospective cohort study
Yuting Gao, Tianyi Zhao, Na Lv, et al.
Endocrine (2024) Vol. 85, Iss. 3, pp. 1178-1192
Closed Access | Times Cited: 3
Yuting Gao, Tianyi Zhao, Na Lv, et al.
Endocrine (2024) Vol. 85, Iss. 3, pp. 1178-1192
Closed Access | Times Cited: 3
Anti-Diabetic Effects of Allulose in Diet-Induced Obese Mice via Regulation of mRNA Expression and Alteration of the Microbiome Composition
Youngji Han, Eun‐Young Kwon, Myung‐Sook Choi
Nutrients (2020) Vol. 12, Iss. 7, pp. 2113-2113
Open Access | Times Cited: 22
Youngji Han, Eun‐Young Kwon, Myung‐Sook Choi
Nutrients (2020) Vol. 12, Iss. 7, pp. 2113-2113
Open Access | Times Cited: 22
Effects of vancomycin‐induced gut microbiome alteration on the pharmacodynamics of metformin in healthy male subjects
Eunwoo Kim, Andrew Hyoungjin Kim, Yujin Lee, et al.
Clinical and Translational Science (2021) Vol. 14, Iss. 5, pp. 1955-1966
Open Access | Times Cited: 19
Eunwoo Kim, Andrew Hyoungjin Kim, Yujin Lee, et al.
Clinical and Translational Science (2021) Vol. 14, Iss. 5, pp. 1955-1966
Open Access | Times Cited: 19
Impact of non-antibiotic drugs on the human intestinal microbiome
Quentin Le Bastard, Laureline Berthelot, Jean‐Paul Soulillou, et al.
Expert Review of Molecular Diagnostics (2021) Vol. 21, Iss. 9, pp. 911-924
Closed Access | Times Cited: 19
Quentin Le Bastard, Laureline Berthelot, Jean‐Paul Soulillou, et al.
Expert Review of Molecular Diagnostics (2021) Vol. 21, Iss. 9, pp. 911-924
Closed Access | Times Cited: 19
Human gut microbiome: Therapeutic opportunities for metabolic syndrome—Hype or hope?
Angela Horvath, Kristina Žukauskaitė, Olha Hazia, et al.
Endocrinology Diabetes & Metabolism (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 7
Angela Horvath, Kristina Žukauskaitė, Olha Hazia, et al.
Endocrinology Diabetes & Metabolism (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 7
Gut microbiota in relationship to diabetes mellitus and its late complications with a focus on diabetic foot syndrome: A review
Hana Sechovcová, Tiziana Maria Mahayri, Jakub Mrázek, et al.
Folia Microbiologica (2023) Vol. 69, Iss. 2, pp. 259-282
Closed Access | Times Cited: 7
Hana Sechovcová, Tiziana Maria Mahayri, Jakub Mrázek, et al.
Folia Microbiologica (2023) Vol. 69, Iss. 2, pp. 259-282
Closed Access | Times Cited: 7
Beneficial effects of lactitol on the composition of gut microbiota in constipated patients
Xiao Qing Li, Xu Min Zhang, Xi Wu, et al.
Journal of Digestive Diseases (2020) Vol. 21, Iss. 8, pp. 445-453
Closed Access | Times Cited: 19
Xiao Qing Li, Xu Min Zhang, Xi Wu, et al.
Journal of Digestive Diseases (2020) Vol. 21, Iss. 8, pp. 445-453
Closed Access | Times Cited: 19
Holistic perspective of the role of gut microbes in diabetes mellitus and its management
Kannayiram Alagiakrishnan, Tyler Halverson
World Journal of Diabetes (2021) Vol. 12, Iss. 9, pp. 1463-1478
Open Access | Times Cited: 18
Kannayiram Alagiakrishnan, Tyler Halverson
World Journal of Diabetes (2021) Vol. 12, Iss. 9, pp. 1463-1478
Open Access | Times Cited: 18
